The Journal of Urology
Volume 175, Issue 3 , Pages 1058-1062, March 2006

Self-Esteem, Confidence and Relationship Satisfaction of Men With Erectile Dysfunction Treated With Sildenafil Citrate: A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled Study in the United States

  • Michael P. O’Leary

      Affiliations

    • Department of Surgery, Harvard Medical School, and Division of Urology, Brigham and Women’s Hospital, Boston, Massachusetts
    • Financial interest and/or other relationship with Pfizer Inc, Sanofi and Boehringer-Ingelheim.
    • Corresponding Author InformationCorrespondence: Department of Surgery, Harvard Medical School, Division of Urology, Brigham and Women’s Hospital, 45 Francis St., Boston, Massachusetts 02115-6105 (telephone: 617-732-6325; FAX: 617-566-3475)
  • ,
  • Stanley E. Althof

      Affiliations

    • Case Western Reserve University School of Medicine, Beachwood, Ohio
    • Financial interest and/or other relationship with Bayer/GSK, Lilly/ICOS, Alza/Johnson and Johnson, Pfizer Inc, Sanofi Synthelabo, Auxilium and Solvay.
  • ,
  • Joseph C. Cappelleri

      Affiliations

    • Pfizer Inc, Global Research and Development, Groton, Connecticut
    • Financial interest and/or other relationship with Pfizer Inc.
  • ,
  • Arthur Crowley

      Affiliations

    • Pfizer Inc, New York, New York
    • Financial interest and/or other relationship with Pfizer Inc.
  • ,
  • Nancy Sherman

      Affiliations

    • Pfizer Inc, New York, New York
    • Financial interest and/or other relationship with Pfizer Inc.
  • ,
  • Sandeep Duttagupta

      Affiliations

    • Pfizer Inc, New York, New York
    • Financial interest and/or other relationship with Pfizer Inc.
  • ,
  • The United States Self-Esteem and Relationship Questionnaire Study Group

Received 13 April 2005

Purpose

We assessed the change in confidence, relationships and self-esteem, and its correlation with erectile function in men with ED treated with sildenafil citrate in the first United States based, double-blind, placebo controlled, randomized trial assessed by the validated SEAR.

Materials and Methods

This 12-week flexible dose (25, 50 or 100 mg) trial determined change scores from baseline to end of treatment for the 5 SEAR components (Sexual Relationship domain, Confidence domain, Self-Esteem subscale [prespecified as the primary end point], Overall Relationship subscale and Overall score), and their correlations with the IIEF and event log data, as well as correlations between SEAR components and a general efficacy question at the end of treatment.

Results

Compared with the placebo group (125 patients, mean age ± SD 55 ± 13 years, mean years ED 3.8 ± 4.2), the sildenafil group (128 patients, mean age ± SD 56 ± 12, mean years ED 4.6 ± 4.3) had significantly greater improvements in all 5 SEAR components (p <0.0001) and all sexual function measures. SEAR component scores showed significant correlations with IIEF Erectile Function domain scores (r range 0.34 to 0.69, p <0.0001), other IIEF domain scores (p <0.0001), percentage of successful intercourse attempts (p <0.0001) and frequency of erection that allowed satisfactory intercourse (p <0.0001).

Conclusions

In this study of men with ED, sildenafil produced substantial improvements in self-esteem, confidence and relationship satisfaction as measured by SEAR scores, which showed moderate to high positive correlations with IIEF scores.

Key Words:  impotence , self concept , quality of life , psychometrics

Abbreviations and Acronyms:  CI, confidence interval , ED, erectile dysfunction , EF, erectile function , GEQ, global efficacy question , IIEF, International Index of Erectile Function , SD, standard deviation , SEAR, Self-Esteem And Relationship questionnaire

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received local Institutional Review Board approval.

PII: S0022-5347(05)00418-0

doi:10.1016/S0022-5347(05)00418-0

Refers to article:

  • Role of Nitric Oxide in the Relaxation Elicited by Sildenafil in Penile Resistance Arteries

    Dolores Prieto, Luis Rivera, Paz Recio, José Luis Ruiz Rubio, Medardo Hernández, Albino García-Sacristán
    The Journal of Urology March 2006 (Vol. 175, Issue 3, Pages 1164-1170)

The Journal of Urology
Volume 175, Issue 3 , Pages 1058-1062, March 2006